Trial Profile
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2016
Price :
$35
*
At a glance
- Drugs Ulobetasol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Jun 2012 New trial record